The Mental Health Debate

We have two sides of a debate: One says the mental health drugs are the only option and the other says the drugs cause mental health problems.

The drugs’ side gives lots of false information to the public.

The other side gives lots of facts to disprove the falsities.

Yet, the public, largely, goes for the drugs’ side. Despite the facts that show there is no basis in science for the use of the drugs and despite the facts that show the financial incentives for why people are being given drugs they don’t need, the public goes for the “experts”.

There is even a test to evidence how poor someone will metabolize the drug and yet the drugs’ side is using that test to apparently adjust the drug dose or choice of drug so the person “has the best chance they can get”.

When in reality the most important facts are that it is normal to experience anxiety, sadness, grief and an entire list of emotions in response to life’s stresses. Additionally, if one wants to introduce science and medical evidence to the list of options, there are medical ailments that cause mental health problems and those ailments can be tested for and can be treated with non-mental health treatments that effectively cure the person of the cause for those symptoms and behaviors.

Why dose a drug; why test to see the metabolic rate for a drug that is not medically needed; why not simply find the medical ailment and cure it. Why live a life of mental health drugs and adverse consequences?

The subject of drugs (pharma) and genetics (the study of inherited characteristics) is called “Pharacogenomics”.

Pharmacogenomics looks at how specific genetic characteristics influence medication response. The medical community has had a medical test, for years, which can evidence the inability of a person’s body, to assimilate and utilize a drug.

Individual differences in drug metabolism are due to differences in the activity of enzymes (electron transfer agents in metabolic pathways) that metabolize the majority of drugs.

The enzymes are affected by and will produce varying behaviors by over 50 different genes and these genes and the varying behaviors have been studied and evidenced by medical science, yet the public is not made aware that this test exists. This includes testing for drugs that are prescribed for physical ailments as well as mental health symptoms

In addition to the 50 different genes that affect whether someone can utilize the drug, without having adverse reactions and potentially fatal consequences, there are a group of enzymes that have several different versions of each enzyme due to one’s genetic make-up. There are, also, proteins, within the body that play a role in whether the body can break down and assimilate a drug or whether the drug will simply act as a toxin. This adds up to a lot of variables that determine whether an individual can predict that they are likely to experience the FDA adverse effect warnings of mania, psychosis, hallucinations, sudden death, paranoia, delusions, suicidal thoughts and homicidal thoughts and more.

The absorption, distribution, metabolism or elimination of the drug is all influenced by hereditary factors.

In summation, genetic variants can occur at any step in the drug metabolism pathway, in both the genes that make receptor proteins and the genes that make various drug-metabolizing enzymes.